Siga Technologies Inc (SIGA): R&D Expense
$19.96M
Year ended 2025-12-31
$20.43M
Trailing 12 months to 2026-06-30
-4.0%
3-year compound annual growth
+12.8%
5-year compound annual growth
+4.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.96M | +62.1% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $12.31M | -25.1% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $16.43M | -27.1% | 2026-03-10, From 2023-01-01 |
| 2022-12-31 | $22.53M | +126.6% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $9.94M | -9.1% | 2024-03-12, From 2021-01-01 |
| 2020-12-31 | $10.94M | -17.8% | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | $13.30M | +2.2% | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | $13.02M | -22.0% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $16.68M | -15.4% | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | $19.71M | +50.1% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $13.13M | +22.6% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $10.71M | -22.3% | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | $13.79M | -24.3% | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | $18.21M | -0.8% | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $18.37M | -18.9% | 2014-03-10, From 2011-01-01 |
| 2010-12-31 | $22.66M | +30.0% | 2013-05-15, From 2010-01-01 |
| 2009-12-31 | $17.42M | n/a | 2012-03-01, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Siga Technologies Inc (SIGA) | 2025-12-31 | $19.96M | +62.1% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $416.03M | +22.6% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $25.99M | -9.9% |
| Zymeworks Inc. (ZYME) | 2025-12-31 | $137.00M | +1.8% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $13.18M | -32.7% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $12.74M | -69.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $316.90M | +43.0% |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $37.41M | -0.6% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $112.21M | -42.5% |
Compare SIGA, CYTK, LAB, ZYME side by side · Screen every company in Pharmaceutical Preparations ↗